increased B cell derived lymphoma incidence_Cdkn1a<tm1Tyj>/Cdkn1a<tm1Tyj>

http://metadb.riken.jp/0002023I129S2SvPasC57BL6Cdkn1atm1TyjCdkn1atm1TyjCdkn1atm1Tyj

increased B cell derived lymphoma incidence_Cdkn1a<tm1Tyj>/Cdkn1a<tm1Tyj>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• cyclin-dependent kinase inhibitor 1A (P21)
  http://metadb.riken.jp/db/mgi_rdf/MGI:104556

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Cdkn1a<tm1Tyj>/Cdkn1a<tm1Tyj>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Cdkn1a<tm1Tyj>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129S2/SvPas * C57BL/6

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• increased B cell derived lymphoma incidence
  http://purl.obolibrary.org/obo/MP_0002023

文献

http://purl.org/net/cito/citesAsAuthority

• J. Martín-Caballero, et.al., Tumor susceptibility of p21(Waf1/Cip1)-deficient mice., Cancer research, 2001, 61
  http://rdf.ncbi.nlm.nih.gov/pubmed/11507077